appendix 3b new shares, page-51

You're not the only one, Jawdan. The problem is that many posters are not being sceptical, so much as contrarian and negative. As she's on ignore, I don't know if she's still posting, but if you look at Traderlilly's posting after the HD results, she wasn't being rigourous, she was making arguments based on false assumptions, e.g. no efficacy endpoints were met, and that the whole purpose of the trial was to meet efficacy endpoints.

So far, this company looks very promising. Doesn't mean it will deliver. IMO it will, but I don't know much about this game. Seemingly promising drugs fail all the time. But nobody's helped if posters are using sophistry - negative or positive.